Different manifestations of patients with inhibitors against prothrombin and thrombin

J Thromb Thrombolysis. 2020 Jan;49(1):164-167. doi: 10.1007/s11239-019-01948-0.

Authors

Ning Tang¹, Dengju Li²

Affiliations

¹ Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
² Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan City, Hubei Province, China. lidengju2019@126.com.

PMID: 31549352
DOI: 10.1007/s11239-019-01948-0

No abstract available

Publication types

Case Reports

MeSH terms

Blood Coagulation Factor Inhibitors / blood*
Female
Hemorrhage / blood*
Hemorrhage / drug therapy
Humans
Hypoprothrombinemias / blood*
Hypoprothrombinemias / drug therapy
Male
Middle Aged
Prothrombin* / antagonists & inhibitors
Prothrombin* / metabolism
Thrombin* / antagonists & inhibitors
Thrombin* / metabolism

Substances

Blood Coagulation Factor Inhibitors
Prothrombin
Thrombin